Zhenlei Zhang

机构：Sir Run Run Shaw Hospital, Guangxi Normal University · ORCID：0000-0003-0481-9817

发表论文 72 篇 · 总被引 1191 次 · h-index 24

代表论文

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer (2022 · Journal of Medicinal Chemistry · 被引 66)
Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response (2024 · Journal of Medicinal Chemistry · 被引 62)
Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin (2023 · Journal of Medicinal Chemistry · 被引 60)
Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin (2023 · Journal of Medicinal Chemistry · 被引 46)
Current status of iridium-based complexes against lung cancer (2022 · Frontiers in Pharmacology · 被引 46)
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer (2023 · Journal of Medicinal Chemistry · 被引 44)